Latest Breaking News On - Neurology at harvard medical school - Page 6 : comparemela.com

Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference

/PRNewswire/ Beacon Biosignals CEO and co-founder Jacob Donoghue, MD, Ph.D., will be speaking at the Precision Medicine World Conference (PMWC) 2023 being.

United statesSanta claraAlex shermanMegan moriartyJacob donoghueNeurology at harvard medical schoolAmendola communications for beacon biosignalsNeurological clinical research institute at massachusettsHealth sciences technologyHarvard medical schoolSanta clara convention centerPrecision medicine world conferenceSilicon valleyPatient outcomes predictionDrug discoveryClinical research

Brain-computer interfaces safety is similar to other implanted neurologic devices, study shows

For people with paralysis caused by neurologic injury or disease-;such as ALS (also known as Lou Gehrig's disease), stroke, or spinal cord injury-;brain-computer interfaces (BCIs) have the potential to restore communication, mobility, and independence by transmitting information directly from the brain to a computer or other assistive technology.

United statesLou gehrigSeanm healeyLeigh hochbergLee hochbergDaniel rubinEmily hendersonNeurology at harvard medical schoolDepartment of neurologyVa rrd centerBraingate neural interfaceHarvard medicalDiscovery industry focusBallou university professorBrown universityHealthcare system

Low Rate of Adverse Events in Brain Computer Interface Trial

Low Rate of Adverse Events in Brain Computer Interface Trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesLee hochbergZivm williamsMaryam masoodLou gehrigSeanm healeyRose marujoLeigh hochbergDaniel rubinBrown university office of the viceRehabilitation researchDeane instituteCommittee on researchUniversity of chicagoSargent rehabilitation center

uniQure (QURE) Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event

uniQure (QURE) Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRicardo dolmetschEllen bubrickPierre calozAdvances in manufacturing platform technologyNeurology at harvard medical schoolEpilepsy surgery program at brighamWall streetHarvard medical schoolEpilepsy surgery programTemporal lobe epilepsyManufacturing platform technologyTemporal lobe epilepsytemporal

Epilepsy and Alzheimer s disease: Are there connections?

Alzheimer s disease is a risk factor for epilepsy - and epilepsy is a risk factor for Alzheimer s. We spoke with Dr. Andrew Cole and Dr. Alice Lam about the lat

United statesDavid holtzmanJeff noebelsAndrew coleBob kaliffPatricia salettiKeith vosselLennart muckeNancy volkersNat neurosciNeurology at harvard medical schoolInternational league against epilepsyHarvard medical schoolSharp wavesApple podcastsGoogle podcasts